WT1 HLA class II-binding peptides and compositions and methods comprising same
US-12528849-B2 · Jan 20, 2026 · US
Scheinberg David is listed as an inventor on 20 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Scheinberg David |
| Total patents | 20 |
| First publication | Sep 17, 2015 |
| Latest publication | Jan 20, 2026 |
Publications ranked by popularity score, then publication date.
US-12528849-B2 · Jan 20, 2026 · US
US-2023346988-A1 · Nov 2, 2023 · US
US-2023348853-A1 · Nov 2, 2023 · US
US-2023265122-A1 · Aug 24, 2023 · US
US-11548924-B2 · Jan 10, 2023 · US
US-2022380423-A1 · Dec 1, 2022 · US
US-11414457-B2 · Aug 16, 2022 · US
US-11033613-B2 · Jun 15, 2021 · US
US-2021163624-A1 · Jun 3, 2021 · US
US-10858444-B2 · Dec 8, 2020 · US
Latest publications not already listed above.
US-2019322713-A1 · Oct 24, 2019 · US
US-2019270776-A1 · Sep 5, 2019 · US
US-2019144563-A1 · May 16, 2019 · US
US-10239952-B2 · Mar 26, 2019 · US
US-10040865-B2 · Aug 7, 2018 · US
US-2017088630-A1 · Mar 30, 2017 · US
US-9540448-B2 · Jan 10, 2017 · US
US-2016369006-A1 · Dec 22, 2016 · US
US-2016280796-A1 · Sep 29, 2016 · US
US-2015259436-A1 · Sep 17, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Memorial Sloan Kettering Cancer Center | 19 |
| Eureka Therapeutics Inc | 10 |
| Sloan Kettering Inst Cancer | 1 |
| Novartis Ag | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 16 |
| A61P35/02 | 12 |
| A61K2039/505 | 12 |
| C07K2317/31 | 11 |
| C07K2317/622 | 11 |